Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1473 entries
Sorted by: Best Match Show Resources per page
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

The Cochrane database of systematic reviews

Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, Woodward NE.
PMID: 35005781
Cochrane Database Syst Rev. 2022 Jan 10;1:CD013167. doi: 10.1002/14651858.CD013167.pub2.

BACKGROUND: Adjuvant aromatase inhibitors (AI) improve survival compared to tamoxifen in postmenopausal women with hormone receptor-positive stage I to III breast cancer. In approximately half of these women, AI are associated with aromatase inhibitor-induced musculoskeletal symptoms (AIMSS), often described...

Cite
Roberts KE, Adsett IT, Rickett K, et al. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022;1:CD013167doi: 10.1002/14651858.CD013167.pub2.
Roberts, K. E., Adsett, I. T., Rickett, K., Conroy, S. M., Chatfield, M. D., & Woodward, N. E. (2022). Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. The Cochrane database of systematic reviews, 1CD013167. https://doi.org/10.1002/14651858.CD013167.pub2
Roberts, Kate E, et al. "Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer." The Cochrane database of systematic reviews vol. 1 (2022): CD013167. doi: https://doi.org/10.1002/14651858.CD013167.pub2
Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, Woodward NE. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022 Jan 10;1:CD013167. doi: 10.1002/14651858.CD013167.pub2. PMID: 35005781; PMCID: PMC8743877.
Copy Download .nbib Format: NLM
Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer.

The Cochrane database of systematic reviews

Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, Woodward NE.
PMID: 35005781
Cochrane Database Syst Rev. 2022 Jan 10;1:CD013167. doi: 10.1002/14651858.CD013167.pub2.

BACKGROUND: Adjuvant aromatase inhibitors (AI) improve survival compared to tamoxifen in postmenopausal women with hormone receptor-positive stage I to III breast cancer. In approximately half of these women, AI are associated with aromatase inhibitor-induced musculoskeletal symptoms (AIMSS), often described...

Cite
Roberts KE, Adsett IT, Rickett K, et al. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022;1:CD013167doi: 10.1002/14651858.CD013167.pub2.
Roberts, K. E., Adsett, I. T., Rickett, K., Conroy, S. M., Chatfield, M. D., & Woodward, N. E. (2022). Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. The Cochrane database of systematic reviews, 1CD013167. https://doi.org/10.1002/14651858.CD013167.pub2
Roberts, Kate E, et al. "Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer." The Cochrane database of systematic reviews vol. 1 (2022): CD013167. doi: https://doi.org/10.1002/14651858.CD013167.pub2
Roberts KE, Adsett IT, Rickett K, Conroy SM, Chatfield MD, Woodward NE. Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer. Cochrane Database Syst Rev. 2022 Jan 10;1:CD013167. doi: 10.1002/14651858.CD013167.pub2. PMID: 35005781.
Copy Download .nbib Format: NLM
Interventions for preventing bone disease in kidney transplant recipients.

The Cochrane database of systematic reviews

Palmer SC, Chung EY, McGregor DO, Bachmann F, Strippoli GF.
PMID: 31637698
Cochrane Database Syst Rev. 2019 Oct 22;10:CD005015. doi: 10.1002/14651858.CD005015.pub4. Epub 2019 Oct 22.

BACKGROUND: People who have chronic kidney disease (CKD) have important changes to bone structure, strength, and metabolism. Children experience bone deformity, pain, and delayed or impaired growth. Adults experience limb and vertebral fractures, avascular necrosis, and pain. The fracture...

Cite
Palmer SC, Chung EY, McGregor DO, et al. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2019;10:CD005015doi: 10.1002/14651858.CD005015.pub4.
Palmer, S. C., Chung, E. Y., McGregor, D. O., Bachmann, F., & Strippoli, G. F. (2019). Interventions for preventing bone disease in kidney transplant recipients. The Cochrane database of systematic reviews, 10CD005015. https://doi.org/10.1002/14651858.CD005015.pub4
Palmer, Suetonia C, et al. "Interventions for preventing bone disease in kidney transplant recipients." The Cochrane database of systematic reviews vol. 10 (2019): CD005015. doi: https://doi.org/10.1002/14651858.CD005015.pub4
Palmer SC, Chung EY, McGregor DO, Bachmann F, Strippoli GF. Interventions for preventing bone disease in kidney transplant recipients. Cochrane Database Syst Rev. 2019 Oct 22;10:CD005015. doi: 10.1002/14651858.CD005015.pub4. Epub 2019 Oct 22. PMID: 31637698; PMCID: PMC6803293.
Copy Download .nbib Format: NLM
MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells.

Journal of orthopaedic translation

Sun X, Li X, Qi H, Hou X, Zhao J, Yuan X, Ma X.
PMID: 32695607
J Orthop Translat. 2020 May 19;24:76-87. doi: 10.1016/j.jot.2020.04.007. eCollection 2020 Sep.

OBJECTIVE: The healing of osteoporotic fractures in the elderly patients is a difficult clinical problem. Currently, based on the internal fixation of fractures, the available drug treatments mainly focus on either inhibiting osteoclast function, such as bisphosphonate, calcitonin, oestrogen...

Cite
Sun X, Li X, Qi H, et al. MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells. J Orthop Translat. 2020;24:76-87doi: 10.1016/j.jot.2020.04.007.
Sun, X., Li, X., Qi, H., Hou, X., Zhao, J., Yuan, X., & Ma, X. (2020). MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells. Journal of orthopaedic translation, 2476-87. https://doi.org/10.1016/j.jot.2020.04.007
Sun, Xiaolei, et al. "MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells." Journal of orthopaedic translation vol. 24 (2020): 76-87. doi: https://doi.org/10.1016/j.jot.2020.04.007
Sun X, Li X, Qi H, Hou X, Zhao J, Yuan X, Ma X. MiR-21 nanocapsules promote early bone repair of osteoporotic fractures by stimulating the osteogenic differentiation of bone marrow mesenchymal stem cells. J Orthop Translat. 2020 May 19;24:76-87. doi: 10.1016/j.jot.2020.04.007. eCollection 2020 Sep. PMID: 32695607; PMCID: PMC7349941.
Copy Download .nbib Format: NLM
Is it safe to place implants in patients at risk of MRONJ?.

Evidence-based dentistry

Owen B, Bradley H.
PMID: 34561663
Evid Based Dent. 2021 Jan;22(3):108-109. doi: 10.1038/s41432-021-0196-9.

Data sources Four electronic databases, namely PubMed, Scopus, Web of Science and the Cochrane Central Register of Controlled Trials, were searched from their inception to 16 July 2019. The OpenGrey database was also used to identify unpublished studies.Study selection...

Cite
Owen B, Bradley H. Is it safe to place implants in patients at risk of MRONJ?. Evid Based Dent. 2021;22(3):108-109doi: 10.1038/s41432-021-0196-9.
Owen, B., & Bradley, H. (2021). Is it safe to place implants in patients at risk of MRONJ?. Evidence-based dentistry, 22(3), 108-109. https://doi.org/10.1038/s41432-021-0196-9
Owen, Brandon, and Bradley, Hannah. "Is it safe to place implants in patients at risk of MRONJ?." Evidence-based dentistry vol. 22,3 (2021): 108-109. doi: https://doi.org/10.1038/s41432-021-0196-9
Owen B, Bradley H. Is it safe to place implants in patients at risk of MRONJ?. Evid Based Dent. 2021 Jan;22(3):108-109. doi: 10.1038/s41432-021-0196-9. PMID: 34561663.
Copy Download .nbib Format: NLM
[Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Schmerz (Berlin, Germany)

Cherny NI, Portenoy RK, Raber M, Zenz M.
PMID: 18415535
Schmerz. 1995 Mar;9(2):55-69. doi: 10.1007/BF02528536.

Adjuvant analgesics are drugs that are not primarily used as analgesics but can produce analgesia in certain types of pain. Adjuvant analgesics can be administered together with non-opioid and opioid analgesics on each step of the WHO analgesic ladder....

Cite
Cherny NI, Portenoy RK, Raber M, et al. Medikamentöse Therapie von Tumorschmerzen : Teil III: Adjuvanzien. [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]. Schmerz. 1995;9(2):55-69doi: 10.1007/BF02528536.
Cherny, N. I., Portenoy, R. K., Raber, M., & Zenz, M. (1995). Medikamentöse Therapie von Tumorschmerzen : Teil III: Adjuvanzien. [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]. Schmerz (Berlin, Germany), 9(2), 55-69. https://doi.org/10.1007/BF02528536
Cherny, N I, et al. "Medikamentöse Therapie von Tumorschmerzen : Teil III: Adjuvanzien." [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]. Schmerz (Berlin, Germany) vol. 9,2 (1995): 55-69. doi: https://doi.org/10.1007/BF02528536
Cherny NI, Portenoy RK, Raber M, Zenz M. Medikamentöse Therapie von Tumorschmerzen : Teil III: Adjuvanzien. [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.]. Schmerz. 1995 Mar;9(2):55-69. doi: 10.1007/BF02528536. German. PMID: 18415535.
Copy Download .nbib Format: NLM
Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats.

Journal of ethnopharmacology

Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y.
PMID: 34896207
J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09.

ETHNOPHARMACOLOGICAL RELEVANCE: 'Cold feeling' is a subjective feeling of unusual coldness that aggravates fatigue, stiffness, and other symptoms, thereby reducing quality of life. Tokishakuyakusan (TSS) is a Kampo medicine reported to improve cold feeling and is used to treat...

Cite
Shimizu T, Terawaki K, Sekiguchi K, et al. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021;285:114896doi: 10.1016/j.jep.2021.114896.
Shimizu, T., Terawaki, K., Sekiguchi, K., Sanechika, S., Ohbuchi, K., Matsumoto, C., & Ikeda, Y. (2021). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of ethnopharmacology, 285114896. https://doi.org/10.1016/j.jep.2021.114896
Shimizu, Tomofumi, et al. "Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats." Journal of ethnopharmacology vol. 285 (2021): 114896. doi: https://doi.org/10.1016/j.jep.2021.114896
Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09. PMID: 34896207.
Copy Download .nbib Format: NLM
Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats.

Journal of ethnopharmacology

Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y.
PMID: 34896207
J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09.

ETHNOPHARMACOLOGICAL RELEVANCE: 'Cold feeling' is a subjective feeling of unusual coldness that aggravates fatigue, stiffness, and other symptoms, thereby reducing quality of life. Tokishakuyakusan (TSS) is a Kampo medicine reported to improve cold feeling and is used to treat...

Cite
Shimizu T, Terawaki K, Sekiguchi K, et al. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021;285:114896doi: 10.1016/j.jep.2021.114896.
Shimizu, T., Terawaki, K., Sekiguchi, K., Sanechika, S., Ohbuchi, K., Matsumoto, C., & Ikeda, Y. (2021). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of ethnopharmacology, 285114896. https://doi.org/10.1016/j.jep.2021.114896
Shimizu, Tomofumi, et al. "Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats." Journal of ethnopharmacology vol. 285 (2021): 114896. doi: https://doi.org/10.1016/j.jep.2021.114896
Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09. PMID: 34896207.
Copy Download .nbib Format: NLM
Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats.

Journal of ethnopharmacology

Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y.
PMID: 34896207
J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09.

ETHNOPHARMACOLOGICAL RELEVANCE: 'Cold feeling' is a subjective feeling of unusual coldness that aggravates fatigue, stiffness, and other symptoms, thereby reducing quality of life. Tokishakuyakusan (TSS) is a Kampo medicine reported to improve cold feeling and is used to treat...

Cite
Shimizu T, Terawaki K, Sekiguchi K, et al. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021;285:114896doi: 10.1016/j.jep.2021.114896.
Shimizu, T., Terawaki, K., Sekiguchi, K., Sanechika, S., Ohbuchi, K., Matsumoto, C., & Ikeda, Y. (2021). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of ethnopharmacology, 285114896. https://doi.org/10.1016/j.jep.2021.114896
Shimizu, Tomofumi, et al. "Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats." Journal of ethnopharmacology vol. 285 (2021): 114896. doi: https://doi.org/10.1016/j.jep.2021.114896
Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09. PMID: 34896207.
Copy Download .nbib Format: NLM
Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats.

Journal of ethnopharmacology

Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y.
PMID: 34896207
J Ethnopharmacol. 2022 Mar 01;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09.

ETHNOPHARMACOLOGICAL RELEVANCE: 'Cold feeling' is a subjective feeling of unusual coldness that aggravates fatigue, stiffness, and other symptoms, thereby reducing quality of life. Tokishakuyakusan (TSS) is a Kampo medicine reported to improve cold feeling and is used to treat...

Cite
Shimizu T, Terawaki K, Sekiguchi K, et al. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021;285:114896doi: 10.1016/j.jep.2021.114896.
Shimizu, T., Terawaki, K., Sekiguchi, K., Sanechika, S., Ohbuchi, K., Matsumoto, C., & Ikeda, Y. (2022). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of ethnopharmacology, 285114896. https://doi.org/10.1016/j.jep.2021.114896
Shimizu, Tomofumi, et al. "Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats." Journal of ethnopharmacology vol. 285 (2022): 114896. doi: https://doi.org/10.1016/j.jep.2021.114896
Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2022 Mar 01;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09. PMID: 34896207.
Copy Download .nbib Format: NLM
Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats.

Journal of ethnopharmacology

Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y.
PMID: 34896207
J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09.

ETHNOPHARMACOLOGICAL RELEVANCE: 'Cold feeling' is a subjective feeling of unusual coldness that aggravates fatigue, stiffness, and other symptoms, thereby reducing quality of life. Tokishakuyakusan (TSS) is a Kampo medicine reported to improve cold feeling and is used to treat...

Cite
Shimizu T, Terawaki K, Sekiguchi K, et al. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021;285:114896doi: 10.1016/j.jep.2021.114896.
Shimizu, T., Terawaki, K., Sekiguchi, K., Sanechika, S., Ohbuchi, K., Matsumoto, C., & Ikeda, Y. (2021). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of ethnopharmacology, 285114896. https://doi.org/10.1016/j.jep.2021.114896
Shimizu, Tomofumi, et al. "Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats." Journal of ethnopharmacology vol. 285 (2021): 114896. doi: https://doi.org/10.1016/j.jep.2021.114896
Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021 Dec 09;285:114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 09. PMID: 34896207.
Copy Download .nbib Format: NLM
Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats.

Journal of ethnopharmacology

Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y.
PMID: 34896207
J Ethnopharmacol. 2021 Dec 08;114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 08.

ETHNOPHARMACOLOGICAL RELEVANCE: 'Cold feeling' is a subjective feeling of unusual coldness that aggravates fatigue, stiffness, and other symptoms, thereby reducing quality of life. Tokishakuyakusan (TSS) is a Kampo medicine reported to improve cold feeling and is used to treat...

Cite
Shimizu T, Terawaki K, Sekiguchi K, et al. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021;114896doi: 10.1016/j.jep.2021.114896.
Shimizu, T., Terawaki, K., Sekiguchi, K., Sanechika, S., Ohbuchi, K., Matsumoto, C., & Ikeda, Y. (2021). Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. Journal of ethnopharmacology, 114896. https://doi.org/10.1016/j.jep.2021.114896
Shimizu, Tomofumi, et al. "Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats." Journal of ethnopharmacology vol. (2021): 114896. doi: https://doi.org/10.1016/j.jep.2021.114896
Shimizu T, Terawaki K, Sekiguchi K, Sanechika S, Ohbuchi K, Matsumoto C, Ikeda Y. Tokishakuyakusan ameliorates lowered body temperature after immersion in cold water through the early recovery of blood flow in rats. J Ethnopharmacol. 2021 Dec 08;114896. doi: 10.1016/j.jep.2021.114896. Epub 2021 Dec 08. PMID: 34896207.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1473 entries